◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Apotex Health Corp. (APTX) Financial History

Name: Apotex Health Corp. (APTX) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-10-06

Apotex Health Corp. (APTX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toronto, Canada with about 6,000 employees. Its market capitalization is roughly C$7 billion. In the fiscal year ended 2026-03-31, APTX reported C$3.5B in revenue and C$374M in net income.

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

Interactive charts & full statements → Open the APTX valuation workbench →

APTX Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31
Total Revenue	C$3.5B	C$3.3B	C$2.9B
Gross Profit	C$1.9B	C$1.8B	C$1.1B
Operating Income (EBIT)	C$1.0B	C$766M	C$194M
Net Income	C$374M	C$152M	(C$147M)

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APTX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2025-06-30
Total Revenue	C$848M	C$1.1B
Gross Profit	C$421M	C$742M
Operating Income (EBIT)	C$87M	C$508M
Net Income	(C$38M)	C$363M

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APTX Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31
Dividends Paid	(C$1.1B)	(C$164M)	C$0M

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APTX Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31
Total Assets	C$4.5B	C$4.9B	C$4.0B
Total Liabilities	C$5.1B	C$4.6B	C$3.3B

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APTX viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

AMANTA · Amanta Healthcare Limited — ₹8 billion
2186 · Luye Pharma Group Ltd. — HK$7 billion
KILITCH · Kilitch Drugs (India) Limited — ₹7 billion
ZIMLAB · ZIM Laboratories Limited — ₹7 billion
WANBURY · Wanbury Limited — ₹7 billion
VALIANTLAB · Valiant Laboratories Limited — ₹7 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — HK$7 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — HK$6 billion

← APTV All “A” companies APUE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.